1      0

AM21-22: How to Handle Challenging Apheresis Consults

‐ Oct 18, 2021 10:00am

Expiration Date: Dec 31, 2023

Credits: None available.

Therapeutic apheresis is used to treat various types of disorders. The American Society for Apheresis (ASFA) publishes evidence-based guidelines every 3 years to assist apheresis practitioners in the rationale and management of apheresis patients and outlines basic technical specifications for procedures. However, the guidelines provide limited guidance on the urgency of the procedures and only comment on indications with enough published evidence available for categorization. In this session, a summary of the ASFA guidelines and a review of how to perform an apheresis consult will be presented. This session will then discuss how to approach consults with a clinical team, when the indication for a procedure is beyond the ASFA guidelines. Furthermore, the session will address the ethical and legal challenges for these discussions and decisions.

To view Spanish or English subtitles, click the "CC" box in the video player.
Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.

Learning Objectives:

  • Summarize how to approach an apheresis consult, including urgency of the procedure
  • Review examples of challenge issues in rejecting an apheresis request
  • Discuss the potential ethical and legal ramification in apheresis medicine




  • Jaye Barbeau, MD, JD:
    Nothing to Disclose
  • Joseph Schwartz, MD, MPH:
    Consultant: Gamida Cell; Plass-Free, Argen X
  • Huy Pham, MD, MPH:
    Consultant: Sanofi; Honoraria: Argenx; Royalty: Elsevier

All relevant financial relationships have been mitigated. By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.

Credits Available

AM21-22: How to Handle Challenging Apheresis Consults Evaluation